ArticleOncoscience2016

Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide.

Adan Rios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.